ReachMD
ReachMD is a platform designed for healthcare professionals to easily find, engage with, and share medical education and clinical insights through on-demand programming and round-the-clock streaming. The content is available in various formats including video, audio, slides, and written text, accessible through its website, mobile apps, and other platforms. ReachMD's distribution network includes popular sites and apps like iHeartRadio, TuneIn, Stitcher, and iTunes, among others. With over 10,000 medical broadcasts, ReachMD covers topics such as clinical research, medical practices, disease management, and strategies for patient care.
Outlet metrics
Global
#664471
United States
#180046
Health/Medicine
#1407
Articles
-
2 months ago |
reachmd.com | Eric Raible
At one time dismissed or misunderstood, chronic itch has emerged in recent years as a significant focus in dermatology, thanks to advancements in research and treatment. "Itch is finally going mainstream," said dermatologist Dr. Shawn Kwatra (pictured), the Joseph W. Burnett Endowed Professor and Chairman of the department of dermatology at the University of Maryland, in his talk.
-
Sep 3, 2024 |
reachmd.com | Gi-Byoung Nam
This summary is based on the presentation of Gi-Byoung Nam , MD, PhD (Seoul, Republic of Korea) at the ESC Congress 2024 - EPIC-CAD - Edoxaban monotherapy vs. dual antithrombotic therapy for atrial fibrillation and stable coronary artery disease. Introduction and methodsPatients with AF and concomitant coronary artery disease (CAD) require anticoagulation treatment to prevent thromboembolic events and antiplatelet therapy to avoid ischemic events.
-
Aug 28, 2024 |
reachmd.com | Bill Snyder
Pulmonary-renal syndrome (PRS) refers to a group of rare but potentially fatal conditions that nearly always are caused by a misguided attack by the body’s immune system on the lungs and kidneys. Coughing up blood and blood in the urine are telltale signs.
-
Aug 15, 2024 |
reachmd.com | Charlotte Schubert
By: Charlotte Schubert, Ph.D. | August 15, 2024 | 5 min. read | Share Article SummaryA clinical study evaluated whether two biomarkers could predict disease recurrence in head and neck cancer patients. The presence of elevated levels of either biomarker in saliva was associated with recurrence risk. Further development of the approach could lead to new ways to predict if cancer will come back.
-
Jul 3, 2024 |
reachmd.com | Lauren Pastrana
MIAMI - Ultrasound is commonly used for prenatal care and screenings; however, the technology and its uses are evolving and could potentially be the future of treating Alzheimer's disease and other neurodegenerative disorders. Low-Intensity Focused Ultrasound can be used to help disturb the blood-brain barrier. That barrier is meant to shield the brain from toxic substances in the blood.
ReachMD journalists
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Email Patterns
Website
http://reachmd.comTry JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →